Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

STD Bacteria Leads to Potential HIV Infection

By Labmedica International staff writers
Posted on 29 Mar 2012
Print article
African women who are infected with a common sexually transmitted bacterial infection are two times more likely to acquire Human immunodeficiency virus (HIV) infection.

Mycoplasma genitalium is an emerging sexually transmitted infection (STI) associated with reproductive tract syndromes in men causing urethritis, and in women, it is associated with cervicitis and pelvic inflammatory disease.

In a multi-institute study, conducted by the Research Triangle Institute (RTI International; San Francisco, CA, USA) HIV-negative women from Zimbabwe and Uganda were tested once every 12 weeks for a median of 22 months. Blood was collected for HIV diagnosis using several different enzyme-linked immunosorbent assays (ELISA). M. genitalium testing was performed on samples at the HIV detection visit and the last HIV-negative visit for cases, and equivalent visits in follow-up time for controls. Presence of M. genitalium DNA was assessed by in-house polymerase chain reaction (PCR)-ELISA, using the archived cervical swab samples, which had been stored at -20 °C.

The scientists compared 190 women who became infected with HIV during follow-up to women of a comparable age and risk who were not infected with HIV. The team examined women in both groups for the presence of M. genitalium, which was assessed as a risk factor for HIV infection. They found that in initial samples when all participants were HIV free, approximately 15% of women who later developed HIV were infected with M. genitalium compared with 6.5% in women who did not develop the disease. Furthermore, the team found that M. genitalium was more prevalent that other bacterial sexually transmitted diseases caused by Neisseria gonorrhoeae and Chlamydia trachomatis.

According to the team, M. genitalium was responsible for approximately 9% of all HIV infections occurring in the study. Other factors, such as having a partner with HIV risk factors, or the presence of herpes simplex virus 2, which causes genital herpes, were more strongly linked to HIV risk. Sue Napierala Mavedzenge, PhD, a lead researcher of the study, said, "Further research will be required to confirm a causal relationship and to identify risk factors for M. genitalium infection in African populations. If findings from this research are confirmed, M. genitalium screening and treatment among women at high risk for HIV-1 infection may be warranted as part of an HIV-1 prevention strategy.” The study was published March 13, 2012 in the journal AIDS.

Related Links:

Research Triangle Institute



Print article

Channels

Genetic Tests

view channel

Patterns of MicroRNA Expression Distinguish Patients with Asthma and Allergic Rhinitis

Subsets of circulating micro RNAs (miRNAs) are uniquely expressed in asthmatic patients and in patients with allergic rhinitis (AR) and have potential for use as noninvasive biomarkers to diagnose and characterize these diseases. MicroRNAs are a class of about 20 nucleotides-long RNA fragments that block gene expression... Read more

Pathology

view channel

Liver Cancer May Be Diagnosed from Altered Sugar Metabolism

Altered gene expression that causes cancerous cells to metabolize fructose differently from healthy cells could be a significant new biomarker for diagnosing liver cancer. Dietary fructose is primarily metabolized in the liver and it has now been demonstrated that, compared with normal hepatocytes, hepatocellular carcinoma... Read more

Lab Tech.

view channel

Method Preserves Microfluidic Devices for HIV Monitoring in Developing Countries

Microfluidic devices with immunochemistry have broad applications in chemotherapy monitoring, transplant patient monitoring, and especially in monitoring the efficacy of antiretroviral therapy. Providing vital health care services to people in developing countries without reliable electricity, refrigeration and state-of-the-art... Read more

Industry News

view channel

R-Biopharm and Merck Partner on Companion Diagnostics

R-Biopharm AG (Darmstadt, Germany) and Merck KGaA (Darmstadt, Germany) have entered into an agreement that constitutes their first collaboration, which will initially focus on developing and launching companion diagnostics. Companion diagnostics play a central role in personalized medicine by helping to find specific... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.